|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS: | ||||||||||||||||||||
| Real estate: | ||||||||||||||||||||
| Investment properties | ||||||||||||||||||||
| Land and land improvements | ||||||||||||||||||||
| Buildings and improvements | ||||||||||||||||||||
| Total investment properties | ||||||||||||||||||||
| Less accumulated depreciation | ||||||||||||||||||||
| Real estate, net | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Restricted cash | ||||||||||||||||||||
| Receivables, net | ||||||||||||||||||||
| Investment securities - related party | ||||||||||||||||||||
| Assets held for sale | ||||||||||||||||||||
| Above market lease intangibles, net | ||||||||||||||||||||
| Operating lease right-of-use assets | ||||||||||||||||||||
| Deferred costs and other assets, net | ||||||||||||||||||||
| Total Assets | ||||||||||||||||||||
| LIABILITIES: | ||||||||||||||||||||
| Loans payable, net | ||||||||||||||||||||
| Liabilities associated with assets held for sale | ||||||||||||||||||||
| Below market lease intangibles, net | ||||||||||||||||||||
| Derivative liabilities | ||||||||||||||||||||
| Operating lease liabilities | ||||||||||||||||||||
| Series D Preferred Stock redemptions | ||||||||||||||||||||
| Series D Preferred Stock | ||||||||||||||||||||
| Total series D Preferred Stock redemptions | ||||||||||||||||||||
| Accounts payable, accrued expenses and other liabilities | ||||||||||||||||||||
| Total Liabilities | ||||||||||||||||||||
| Series D Cumulative Convertible Preferred Stock | ||||||||||||||||||||
| EQUITY: | ||||||||||||||||||||
| Series A Preferred Stock (no par value, 4,500 shares authorized, 562 shares issued and outstanding; $0.6 million in aggregate liquidation value) Series B Convertible Preferred Stock (no par value, 5,000,000 authorized; 2,659,916 and 2,714,618 shares, respectively, issued and outstanding; $66.5 million and $67.9 million aggregate liquidation preference, respectively) | ||||||||||||||||||||
| Series A Preferred Stock | ||||||||||||||||||||
| Series B Preferred Stock | ||||||||||||||||||||
| Common Stock ($0.01 par value, 200,000,000 shares authorized, 167,781 and 10,530 shares, respectively, issued and outstanding) | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Accumulated other comprehensive income | ||||||||||||||||||||
| Total Shareholders’ Equity | ||||||||||||||||||||
| Noncontrolling interests | ||||||||||||||||||||
| Total Equity | ||||||||||||||||||||
| Total Liabilities and Equity | ||||||||||||||||||||
Loading...
